Efficacy and Safety of Pregabalin in an Open-label, Non-comparative, Flexible-dose Trial With Diabetic Peripheral Neuropathy or Postherpetic Neuralgia.
Phase of Trial: Phase IV
Latest Information Update: 25 Apr 2011
At a glance
- Drugs Pregabalin (Primary)
- Indications Diabetic neuropathies; Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors Pfizer
- 21 Mar 2008 New trial record.